“We don’t agree on a whole lot on this committee,” US House Committee on Oversight and Accountability chair James Comer (R-KY) observed during a 19 September hearing on the pharmacy benefit management sector, “but we agree that PBMs need to be reformed significantly.”
The first half of that comment counts as dramatic understatement.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?